August 2024

Companies discussed include: ANZ Group Holdings (ASX:ANZ)Apple Netwealth Group (ASX:NWL)

As widely expected, New Zealand’s Reserve Bank has made its first cut in interest rates since early 2021. The RBNZ announced a cut of 0.25% in its official cash rate on Wednesday – it had been forecast after the central bank appeared to be moderating its hardline stance on monetary policy over the past two

Like it has boosted its June quarterlies for majors, Barrick and Newmont (ASX:NEM), the surging gold price has burnished the full-year results for local major, Evolution Mining (ASX:EVN). The NSW-focused gold and copper miner saw statutory profit soar 158% to $422.3 million for the year to June on a 44% jump in revenue to $3.215

Kerry Stokes’ Seven Group Holdings (ASX:SVW) saw pre-tax earnings jump 20% for the year to June, as results from two associated companies, Beach Energy and Seven West Media, collapsed in the same period. Commentary from the company made it clear it was its products and services to the mining, construction, and home building sectors—newly boosted

Even AGL Energy (ASX:AGL) thinks its 2023-24 boom can’t be repeated in 2024-25. AGL revealed on Wednesday that its core profit almost trebled due to improved performance at its power stations and higher electricity prices. Shareholders also benefited, with an unfranked dividend nearly doubling from the previous year. However, the company indicated that the high

You can see why shares in Seven West Media (ASX:SWM) have hit new all-time lows of 14 cents this week, as the company revealed a 69% slump in earnings for the year to June. That slide also explains why the company, along with Nine, Ten, and Foxtel, is strongly resisting moves to completely ban gambling

To register for Friday’s webinar click here. Immutep (ASX:IMM) has initiated a Phase I clinical trial to evaluate the safety and efficacy of IMP761, a novel LAG-3 agonist antibody. IMP761 is designed to restore immune system balance by enhancing the hindering function of LAG-3 on T cells, thereby addressing the underlying cause of numerous autoimmune

At 11:35am, the S&P/ASX 200 is 0.7 per cent higher at 7,881.90, driven by a strong performance from the utilities sector, particularly AGL Energy, whose earnings exceeded expectations. This positive market sentiment was further buoyed by optimistic investor expectations of US interest rate cuts, following upbeat US inflation data. The producer price index’s modest 0.1% July

In a potential game-changer for millions of people worldwide, Immutep (ASX:IMM; NASDAQ:IMMP) has initiated the first human trials of IMP761, a novel agonist LAG-3 antibody designed to treat autoimmune diseases. The commencement of this Phase I trial marks a significant milestone for Immutep and the broader field of autoimmune disease research. By targeting the underlying

The Commonwealth Bank (ASX:CBA) has edged up its final dividend for the 2023-24 financial year, despite a dip in revenue and earnings. While the result is solid, it doesn’t appear to justify the 11% surge in the bank’s value over the past three months, propelling it to the title of the country’s most valuable company.